The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Naloxone Protects Rat Dopaminergic Neurons against Inflammatory Damage through Inhibition of Microglia Activation and Superoxide Generation
Abstract
Degeneration of dopaminergicrgic neurons in the substantia nigra of the brain is a hallmark of Parkinson's disease and inflammation and oxidative stress are closely associated with the pathogenesis of degenerative neurological disorders. Treatment of rat mesencephalic mixed neuron-glia cultures with lipopolysaccharide (LPS)-activated microglia, resident immune cells of the brain, to release proinflammatory and neurotoxic factors tumor necrosis factor-alpha, interleukin-1beta, nitric oxide, and superoxide and subsequently caused damage to midbrain neurons, including dopaminergic neurons. The LPS-induced degeneration of the midbrain neurons was significantly reduced by cotreatment with naloxone, an opioid receptor antagonist. This study focused on understanding the mechanism of action for the protective effect of naloxone on dopaminergic neurons because of relevance to Parkinson's disease. Both naloxone and its opioid receptor inactive stereoisomer (+)-naloxone protected the dopaminergic neurons with equal potency. Naloxone inhibited LPS-induced activation of microglia and release of proinflammatory factors, and inhibition of microglia generation of superoxide free radical best correlated with the neuroprotective effect of naloxone isomers. To further delineate the site of action, naloxone was found to partially inhibit the binding of [(3)H]LPS to cell membranes, whereas it failed to prevent damage to dopaminergic neurons by peroxynitrite, a product of nitric oxide and superoxide. These results suggest that naloxone at least in part interferes with the binding of LPS to cell membranes to inhibit microglia activation and protect dopaminergic neurons as well as other neurons in the midbrain cultures from inflammatory damage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alternative drugs with anti-inflammatory properties, including dexamethasone, minocycline, naloxone, are going to be or have already been tested in preclinical and clinical trials.560–562”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [562]
Citations
Cites
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J. A., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,061
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Phylogenetic Perspectives in Innate Immunity
Hoffmann, J. A., Kafatos, F. C., Janeway, C. A., & Ezekowitz, R. A. B. (1999) · Science · doi:10.1126/science.284.5418.1313 · Cited by 2,524
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · cited 1×
“It is well accepted that proinflammatory and cytotoxic factors produced by activated microglia contribute to neurodegeneration and that prevention of microglia activation serves to reduce neuronal injury (McGeer and McGeer, 1995; Epstein, 1998).”
Activated microglia mediate neuronal cell injury via a nitric oxide mechanism
Chao, C. C., Hu, S., Molitor, T. W., Shaskan, E. G., & Peterson, P. K. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.8.2736 · Cited by 1,138
Banati, R. B., Gehrmann, J., Schubert, P., & Kreutzberg, G. W. (1993) · Glia · doi:10.1002/glia.440070117 · Cited by 1,032
Oxidative stress and the pathogenesis of Parkinson's disease
Jenner, P., & Olanow, C. W. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.161s · Cited by 971
Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death
Boje, K. M., & Arora, P. K. (1992) · Brain Research · doi:10.1016/0006-8993(92)91004-x · Cited by 944
Beckman, J. S., Carson, M. A., Smith, C. D. L., & Koppenol, W. H. (1993) · Nature · doi:10.1038/364584a0 · Cited by 876
Cited by
Sorted by citations
Items 201–300 of 346
Vallés, A. S., & Barrantes, F. J. (2023) · Cells · doi:10.3390/cells12162051 · Cited by 37
Role of cinnabar and realgar of WSHFD in protecting against LPS-induced neurotoxicity
Zhang, F., Lu, Y., Wu, Q., Yan, J.-W., Shi, J., & Liu, J. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.12.026 · Cited by 36
Sahakyan, N. Z., Andreoletti, P., Cherkaoui‐Malki, M., Petrosyan, M. T., & Trchоunian, A. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13691 · Cited by 38
Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage
Hu, S., Sheng, W. S., Lokensgard, J. R., Peterson, P. K., & Rock, R. B. (2009) · Journal of NeuroVirology · doi:10.3109/13550280903296346 · Cited by 36
“(Liu et al, 2000; Yang et al, 2007) mesencephalic neuronal/glial cultures.”
Bi, J., Jiang, B., Hao, S., Zhang, A., Dong, Y., Jiang, T., & An, L. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.003 · Cited by 35
CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120
Hu, S., Sheng, W. S., & Rock, R. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077577 · Cited by 34
“Our human mesencephalic neuronal/glial cultures do not contain noradrenergic cells and the relative amount of TH-IR neurons is comparable to what has been reported previously in human (2% to 5%) [52,53] and in rodent (1% to 2%) [54,55] mesencephalic neuronal/glial cultures.”
ResultThe opioid antagonist, β-funaltrexamine, inhibits chemokine expression in human astroglial cells
Davis, R. L., Buck, D. J., Tousi, N. S., & Stevens, C. W. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.03.021 · Cited by 33
Lee, P., Hur, J., Lee, J., Kim, J., Jeong, J., Kang, I., Kim, S. Y., & Kim, H. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.07.004 · Cited by 32
Pintado, C., Revilla, E., Vizuete, M., Jiménez, S., García-Cuervo, L., Vitórica, J., Ruano, D., & Castaño, A. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.06.017 · Cited by 32
“Microglial production of cytotoxic factors after exposure to the proinflamogen lipopolysaccharide (LPS) has been well documented (Boje and Arora, 1992; Chao et al., 1992; Dawson et al., 1994; Kong et al., 1996; Liu et al., 2000).”
BackgroundPolikov, V. S., Su, E. C., Ball, M. A., Hong, J., & Reichert, W. M. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.05.002 · Cited by 32
“…culture system developed for studying adult Parkinson’s disease can reproduce many of the hallmarks of the glial scarring around neuroelectrode materials (Mcmillian et al., 1994;Pennypacker et al., 1996;Liu et al., 2000a;Gao et al., 2003;Qin et al., 2004;Wang et al., 2005;Polikov et al., 2006).”
BackgroundMethodSelf-citationShen, D., Cao, X., Zhao, L., Tuo, J., Wong, W. T., & Chan, C. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6114 · Cited by 31
Cytokines in CNS Inflammation and Disease
Tansey, M. G., & Wyss‐Coray, T. (2007) · Springer eBooks · doi:10.1007/978-0-387-73894-9_5 · Cited by 32
Wu, H.-E., Sun, H.-S., Cheng, C. W., Terashvili, M., & Tseng, L. F. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05144.x · Cited by 30
“In the study with rat mesencephalic neuron–glia cultures, Liu and colleagues (Liu et al., 2000) have demonstrated that dextro-naloxone and levo-naloxone effectively protect dopaminergic neurons from inflammatory damage and significantly inhibit the activation of microglia and their release of proinflammatory cytotoxic…”
BackgroundInfluentialHSP60 is involved in the neuroprotective effects of naloxone
Cheng, W., Li, Y., Hou, X., Zhang, N., Ma, J., Ding, F., LI, F., MIAO, Z., ZHANG, Y., Qi, Q., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2411 · Cited by 30
Microglia and Drug-Induced Plasticity in Reward-Related Neuronal Circuits
Kovács, K. J. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00074 · Cited by 27
A Novel Inhibitory Effect of Naloxone on Macrophage Activation and Atherosclerosis Formation in Mice
Liu, S., Li, Y., Shi, G.-Y., Chen, Y.-H., Huang, C.-W., Hong, J., & Wu, H. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.036 · Cited by 31
Self-citationZito, M. A., Koennecke, L. A., McAuliffe, M. J., McNally, B., van Rooijen, N., & Heyes, M. P. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03135-8 · Cited by 29
Clement, H., Vazquez-Costa, J. F., Sommer, O., Heiser, P., Morawietz, H., Hopt, U. T., Schulz, E., & von Dobschütz, E. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0327-5 · Cited by 29
Covid-19 interface with drug misuse and substance use disorders
Cisneros, I. E., & Cunningham, K. A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108766 · Cited by 30
Davis, R. L., Stevens, C. W., & Curtis, J. T. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.01.037 · Cited by 29
“[27,28] demonstrated that naloxone prevents bacterial LPS from binding to microglia and inhibits microglial superoxide production.”
BackgroundModulators of microglia: a patent review
Papa, S., Caron, I., Rossi, F., & Veglianese, P. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1135901 · Cited by 26
Eslami, F., Rahimi, N., Ostovaneh, A., Ghasemi, M., Dejban, P., Abbasi, A., & Dehpour, A. R. (2020) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12590 · Cited by 26
Essadek, S., Gondcaille, C., Savary, S., Samadi, M. H., Vamecq, J., Lizard, G., Kebbaj, R. E., Latruffe, N., Bénani, A., Nasser, B., et al. (2023) · Antioxidants · doi:10.3390/antiox12010168 · Cited by 26
“The release of ROS by LPS-activated microglia is a key step in the generation of neurotoxicity [11], which can be principally abrogated by neutralizing extracellular hydrogen peroxide and superoxide by catalase and superoxide dismutase treatment, respectively [12,13].”
BackgroundShafie, A., Moradi, F., Izadpanah, E., Mokarizadeh, A., Moloudi, M. R., Nikzaban, M., & Hassanzadeh, K. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.027 · Cited by 26
“Consistent with these results, Hutchinson et al. (2007) and Liu et al.(2000)pioneered studies indicating that opioids, especially morphine, have off-target effects on toll-like receptor 4 (TLR4).”
ResultRegulation of oxidative stress in long‐lived lipopolysaccharide‐activated microglia
Kaneko, Y. S., Ota, A., Nakashima, A., Mori, K., Nagatsu, I., & Nagatsu, T. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2012.05716.x · Cited by 26
Lee, J. A., Son, H. J., Park, K. D., Han, S. H., Shin, N., Kim, J. H., Kim, H. R., Kim, D. J., & Hwang, O. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9550-z · Cited by 25
“Accordingly, compounds that suppress production of the proinflammatory mediators have shown to provide neuroprotection in PD animal models (Liu et al. 2000; Wu et al. 2002; Cho et al. 2009; Ghosh et al. 2009; Son et al. 2012; Lee et al. 2015; Selvakumar et al. 2014; Zhou et al. 2005).”
Kostuk, E. W., Cai, J., & Iacovitti, L. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1181-x · Cited by 26
Prow, N. A., & Irani, D. N. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.013 · Cited by 25
“Activated microglia release cytotoxic substances such as IL-1β, TNFα, superoxide anion, and nitric oxide, all of which may contribute to neuronal cell death in vitro and in vivo (Bronstein et al., 1995; Liu et al., 2000; Takeuchi et al., 1998).”
BackgroundInfluentialChaves, C., Gomez‐Zepeda, D., Auvity, S., Menet, M., Crété, D., Labat, L., Remião, F., Cisternino, S., & Declèves, X. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24697 · Cited by 25
Sayyah, M., Najafabadi, I. T., Beheshti, S., & Majzoob, S. (2003) · Epilepsy Research · doi:10.1016/j.eplepsyres.2003.11.002 · Cited by 25
Liu, Y., Chen, H., & Yang, G.-L. (2010) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x10008251 · Cited by 25
Temporal gene expression patterns in G93A/SOD1 mouse
Chen, L., Smith, A. P., Ben, Y., Zukic, B., Ignacio, S., Moore, D. H., & Lee, N. M. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820410017091 · Cited by 25
Protective effects of naloxone in two‐hit seizure model
Yang, L., Li, F., Ge, W., Mi, C., Wang, R., & Sun, R. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02250.x · Cited by 25
“Recently, in vitro and in vivo studies demonstrated that naloxone was capable of reducing lipopolysaccharide (LPS) and Ab (1-42)- induced morphologic changes of microglia, decreasing production of cytokines, and protecting neurons (Liu et al., 2000a, 2000b, 2000c, 2002).”
BackgroundBurns, L. H., & Wang, H.-Y. (2010) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s4870 · Cited by 24
Modulation of brain apoptosis-related proteins by the opioid antagonist naltrexone in mice
Emeterio, E. P.-S., & Hurlé, M. A. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.04.053 · Cited by 24
Wang, J.-Y., Yang, J.-M., Wang, J., Tao, P., & Yang, S. N. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01780-3 · Cited by 24
Li, Q. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.08.021 · Cited by 23
PTI-609: A Novel Analgesic that Binds Filamin A to Control Opioid Signaling
Burns, L. H., & Wang, H.-Y. (2010) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488910793362386 · Cited by 22
“The initial patent application covered the concept, the screening assay and an early pharmacophore model [35], and several patent applications covering families of these novel compounds have also published [36-38].”
BackgroundNovel strategies in Parkinson’s disease treatment: a review
Mitchell, C. L., & Kurouski, D. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1431079 · Cited by 27
Dong, J., Liu, X., Wang, Y. Y., Cai, H., & Le, W. (2020) · Glia · doi:10.1002/glia.23826 · Cited by 22
Kramer, B. C., Yabut, J. A., Cheong, J., JnoBaptiste, R., Robakis, T. K., Olanow, C. W., & Mytilineou, C. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00310-x · Cited by 22
Effective Doses of Low-Dose Naltrexone for Chronic Pain – An Observational Study
Marcus, N. J., Robbins, L., Araki, A., Gracely, E. J., & Theoharides, T. C. (2024) · Journal of Pain Research · doi:10.2147/jpr.s451183 · Cited by 23
“21 A study of the effect of Naltrexone on inflammation in the collagen-induced arthritis rat model 22 suggests that Naltrexone’s beneficial effect on signs and symptoms of arthritis was mediated through opioid receptors on lymphocytes, suggesting the possible role of neuroimmune modulation in…”
BackgroundNitric oxide induces prion protein via MEK and p38 MAPK signaling
Wang, V., Chuang, T., Hsu, Y., Chou, W., & Kao, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.091 · Cited by 21
Ahmadi, A., Sayyah, M., Khoshkholgh-Sima, B., Choopani, S., Kazemi, J., Sadegh, M., Moradpour, F., & Nahrevanian, H. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3415-6 · Cited by 20
Zheng, L., Zhang, Y., Chen, C., Jin, S., Fan, R.-F., Cai, Q.-Q., Wang, Z.-Y., & Zhu, J. (2013) · Autonomic Neuroscience · doi:10.1016/j.autneu.2013.04.012 · Cited by 20
“LPS is a strong activator of small glial cells and can stimulate these cells to release inflammatory cytokines and cytotoxic factors, which in turn cause the degeneration of dopaminergic neurons (Liu et al., 2000).”
BackgroundMarek, D., Papin, S., Ellefsen, K., Niederhäuser, J., Isidor, N., Ransijn, A., Poupon, L., Spertini, F., Pantaleo, G., Bergmann, S., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-238 · Cited by 20
“Experimental evidence shows that suppression of inflammatory processes mitigates neuronal loss in in vivo and in vitro models of neurodegenerative diseases [15-18].”
BackgroundThomas, J., Lui, L., Abell, A. D., Tieu, W., Somogyi, A. A., Bajic, J. E., & Hutchinson, M. R. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.02.001 · Cited by 20
β-Funaltrexamine Inhibits Inducible Nitric-oxide Synthase Expression in Human Astroglial Cells
Davis, R. L., Buck, D. J., Tousi, N. S., Mohan, S., DeSilva, U., Fernando, S. C., & Stevens, C. W. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9102-x · Cited by 19
“For example, both the MOR inactive stereoisomer (+)-naloxone and (−)-naloxone reduced inflammatory-induced damage of rat dopaminergic neurons, suggesting a potential therapeutic role in the treatment of Parkinson’s disease (Liu et al. 2000).”
Opioid Adjuvant Strategy: Improving Opioid Effectiveness
Bihel, F. J. ‐. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc.15.186 · Cited by 19
Zhou, Y., Wang, G., Li, D., Wang, Y., Wu, Q., Shi, J., & Zhang, F. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1194-5 · Cited by 17
Davis, R. L., Das, S., Curtis, J. T., & Stevens, C. W. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.040 · Cited by 17
“Opioid receptor-independent actions of naloxone include prevention of bacterial LPS-binding to microglia and reduced microglial superoxide production (Liu et al., 2000; 2002).”
BackgroundLPS-induced degeneration of dopaminergic neurons of substantia nigra in rats
Gang, L., Shenggang, S., Xuebing, C., Jiangxin, Z., & E-tang, T. (2004) · Current Medical Science · doi:10.1007/bf02830714 · Cited by 17
CHENG, Y. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2004.04.019 · Cited by 16
Tsai, M., Shyue, S., Weng, C., CHUNG, Y., Liou, D.-Y., Huang, C.-T., Kuo, H., Lee, M.-J., Chang, P., Huang, M., et al. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1338.031 · Cited by 16
Chen, S., Sung, Y., Oyarzabal, E. A., Tan, Y.-M., Leonard, J. A., Guo, M., Li, S., Wang, Q., Chu, C., Chen, S., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0965-4 · Cited by 16
Self-citationSaih, F.-E., Andreoletti, P., Mandard, S., Latruffe, N., Kebbaj, M. S. E., Lizard, G., Nasser, B., & Cherkaoui‐Malki, M. (2017) · Molecules · doi:10.3390/molecules22010102 · Cited by 15
“Generation of ROS by LPS-activated microglia plays a key role in the triggered neurotoxicity [9], which can be largely reduced by neutralizing the extracellular hydrogen peroxide and superoxide by catalase and superoxyde dismutase treatment respectively [10,11].”
BackgroundEffect of Neuroprotective Drugs on Gene Expression in G93A/SOD1 Mice
Ignacio, S., Moore, D. H., Smith, A. P., & Lee, N. M. (2005) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2005.tb00017.x · Cited by 15
Loeliger, M. M., Duncan, J. R., Cock, M. L., Harding, R., & Rees, S. M. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0709 · Cited by 15
Do Bacterial Outer Membrane Vesicles Contribute to Chronic Inflammation in Parkinson’s Disease?
Koukoulis, T. F., Beauchamp, L. C., Kaparakis‐Liaskos, M., McQuade, R. M., Purnianto, A., Finkelstein, D. I., Barnham, K. J., & Vella, L. J. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230315 · Cited by 14
Shi, D., Song, X., Guo, Y., Xu, J., Liu, Y., Zhang, J., Cui, C., & Jin, D. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0890-4 · Cited by 14
Son, H. J., Han, S. H., Lee, J. A., Lee, C.-S., Seo, J. W., Yoon, D., & Hwang, O. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.009 · Cited by 14
He, X., Feng, L., Meng, H., Wang, X., & Liu, S. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.686544 · Cited by 16
“Extracellular superoxide production from microglia was determined by measuring the superoxide dismutase SOD-inhibitable reduction of cytochrome C, as previously described [7].”
BackgroundMethodXu, Y., Fu, L., Jiang, C., Qin, Y., Ni, Y., & Fan, J. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000422 · Cited by 14
Jeohn, G., Cooper, C. L., Jang, K., Kim, H.-C., & Hong, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04079.x · Cited by 14
Self-citationSaminathan, H., Ghosh, A., Zhang, D., Song, C., Jin, H., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.631375 · Cited by 13
Sohn, M., Noh, H.-J., Yoo, I., & Kim, W. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.01.054 · Cited by 13
Neuron–Microglia Contacts Govern the PGE2 Tolerance through TLR4-Mediated de Novo Protein Synthesis
Kuo, H., Lee, K.-F., Chen, S., Chiu, S.-C., Lee, L., Chen, W.-P., Chen, C., & Chu, C. (2022) · Biomedicines · doi:10.3390/biomedicines10020419 · Cited by 13
“Seven days after seeding, the neuron–glia cultures made up of about 10% microglia, 50% astrocytes, and 40% neurons based on the visual counting of immunostained cells with antibodies against cell-type specific markers: neurons (Neu-N), microglia (OX-42), and astrocytes (GFAP) [28].”
Wang, V., Chia, L., Ni, D.-R., Cheng, L., Ho, Y.-P., Cheng, F., & Hong, J. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000013736.80749.4b · Cited by 13
“However, recent studies have shown that the inflammatory reaction induced by lipopolysaccharide (LPS) has a degenerative effect on dopaminergic neurons in vitro (9,10) and in vivo (11,12).”
BackgroundResultSelf-citationThe Degenerating Substantia Nigra as a Susceptible Region for Gene Transfer-Mediated Inflammation
Roca, V., Casabona, J. C., Radice, P. D., Murta, V., & Pitossi, F. J. (2011) · Parkinson s Disease · doi:10.4061/2011/931572 · Cited by 12
Hosseindoost, S., Akbarabadi, A., Sadat‐Shirazi, M., Mousavi, S. M., Khalifeh, S., Mokri, A., Hadjighassem, M., & Zarrindast, M. (2022) · Drug Development Research · doi:10.1002/ddr.21973 · Cited by 11
“lipopolysaccharide (LPS) to the membrane and consequently prevents microglial activation, hence protecting dopaminergic neurons (Liu et al., 2000).”
BackgroundCheng, W., Li, Y., Hou, X., BAI, B., Li, F., Ding, F., Ma, J., Zhang, N., Shen, Y., & Wang, Y. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2794 · Cited by 11
“Previous studies have demonstrated that naloxone, another analogue of morphinan, protects against lipopolysaccharide (LPS)-induced neurotoxicity in vitro and in vivo through the inhibition of the release of proinflammatory factors and free radicals (15-18).”
Venero, J. L., Revuelta, M., Atiki, L., Santiago, M., Tomás‐Camardiel, M., Cano, J., & Machado, A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01191-7 · Cited by 11
Anwar, M. M., Pérez‐Martínez, L., & Pedraza‐Alva, G. (2024) · Immunological Investigations · doi:10.1080/08820139.2024.2358446 · Cited by 11
Neurodegeneration by activated microglia across a nanofiltration membrane
Graber, D. J., Snyder‐Keller, A., Lawrence, D. A., & Turner, J. N. (2011) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20384 · Cited by 9
“Previous studies have reported that dopamine neurons are susceptible to LPS toxicity in mixed neuronglia cultures derived from embryonic ventral mesencephalon cells grown in serum-containing culture medium [14,27].”
ResultArmağan, G., Bojnik, E., Turunç, E., Kanıt, L., Gunduz‐Cinar, O., Benyhe, S., Borsodi, A. D., & Yalçın, A. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.02.015 · Cited by 10
“In addition naloxone is capable of reducing lipopolysaccharide (LPS) and Ab(1–42)-induced morphologic changes of microglia, decreasing the production of cytokines, and protecting neurons (Liu et al., 2000a,b, 2002).”
Meredith, G. E., Dervan, A. G., & Totterdell, S. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-387-28066-9_32 · Cited by 10
Ahn, J., Lee, H. J., Lee, K., Lim, J., Hwang, J. K., Kim, C., Kim, H. A., Kim, H., & Park, H. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e332 · Cited by 10
Kuo, H., Chen, S., Chiu, S.-C., Lee, K.-F., & Chu, C. (2023) · Inflammation · doi:10.1007/s10753-023-01858-7 · Cited by 9
“At the 7th day after seeding, the composition of NG cultures was found to be 11% microglia, 50% astrocytes, and 39% neurons as determined by the visual counting of immunostained cells with antibodies against cell-type specific markers: neurons (neuronal nuclear protein or Neu -N), microglia (OX-42), and astrocytes (gl…”
Reichert, W. M. (2007) · CRC Press eBooks · doi:10.1201/9781420009309-13 · Cited by 9
Neuropsychopharmacological understanding for therapeutic application of morphinans
Shin, E., Hong, J., & Kim, H. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-1009-4 · Cited by 9
Self-citationDown-regulation of microglial activity attenuates axotomized nigral dopaminergic neuronal cell loss
Song, D., Yu, H.-N., Park, C.-R., Lee, J.-S., Lee, J., Park, B.-G., Woo, R., Han, J.-T., Cho, B., & Baik, T. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-112 · Cited by 8
“These events were attenuated by pretreatment with anti-inflammatory agents, such as naloxone [21] and minocycline [22].”
Choi, J. Y., Yun, J., Hwang, C. J., Lee, H. P., Kim, H. D., Chun, H., Park, P., Choi, D. Y., Han, S., & Hong, J. T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112632 · Cited by 8
“For instance, naloxone [32] inhibits microglial activation and reduces superoxide production in the lipopolysaccharide-induced PD model, and vasoactive intestinal peptide [33] blocks microglial activation by decreasing THF-α, IL-1β, and iNOS expression in the MPTP-induced PD model.”
BackgroundSelf-citationJiang, S., Gao, H., Yong, Y., Zhang, H., Li, P., Li, Y., Luo, Q., & Yang, X. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2021.06.007 · Cited by 8
Plank, J. R., Glover, S. C., Moloney, B. D., Hoeh, N. R., Sundram, F., Sumner, R. L., Muthukumaraswamy, S. D., & Lin, J. C. (2022) · Trials · doi:10.1186/s13063-022-06738-3 · Cited by 8
“By blocking TLR-4, the microglia may be prevented from assuming an inflammatory state, thus stopping the release of proinflammatory cytokines and neurotoxic superoxides [33].”
BackgroundYahyavi‐Firouz‐Abadi, N., Tahsili‐Fahadan, P., & Ostad, S. N. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.036 · Cited by 8
Serum‐Dependence of LPS‐Induced Neurotoxicity in Rat Cortical Neurons
Cooper, C. L., Jeohn, G., Tobias, P. S., & Hong, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04076.x · Cited by 8
Self-citationOxidative stress in neurodegenerative diseases: friend and foe
Sasaoka, T. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2012.05723.x · Cited by 7
“Superoxide reacts with excess diffusible NO to form peroxynitrite(17) and ROS generated by activated microglia play a major role in LPS-induced neurotoxicity.(18,19) To counteract the ability of free radicals to negatively affect cellular functions and structural integrity, cells have developed a complex system of enz…”
Characterization of a SILAC method for proteomic analysis of primary rat microglia
Zhang, P., Culver‐Cochran, A. E., Stevens, S. M., & Liu, B. (2016) · PROTEOMICS · doi:10.1002/pmic.201500390 · Cited by 7
“1B), consistent with our previous reports [12,13].”
Self-citationTikamdas, R., Singhal, S. M., Zhang, P., Smith, J. A., Krause, E. G., Stevens, S. M., Song, S., & Liu, B. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14111 · Cited by 7
Self-citationKang, J. M., Jung, J., Kim, H., Lim, H., Jang, S., & Oh, S. (2008) · Archives of Pharmacal Research · doi:10.1007/s12272-001-1275-5 · Cited by 7
“However, inhibition of microglial production of superoxide, but not the other factors, was most effective in protecting neurons, indicating that superoxide was a dominant degenerative factor for the dopaminergic neurons in the culture (Liu et al., 2000).”
Backgroundβ-Funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes
Davis, R. L., Das, S., Buck, D. J., & Stevens, C. W. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.013 · Cited by 7
“Furthermore, it was determined that the inactive stereoisomer, (+)-naloxone, was equally effective as (−)-naloxone (Liu et al., 2000).”
BackgroundMethodResultInfluentialObesity-mediated Lipoinflammation Modulates Food Reward Responses
Huerta, C., Caba, M., & Camacho‐Morales, A. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.08.019 · Cited by 8
Fernagut, P. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00040-4 · Cited by 8
Genetic contributions to influenza virus attenuation in the rat brain
Qi, L., Carbone, K. M., Ye, Z., Liu, T., Ovanesov, M. V., Pletnikov, M. V., Sauder, C. J., & Rubin, S. A. (2008) · Journal of NeuroVirology · doi:10.1080/13550280701885563 · Cited by 6
“These cultures consist of approximately 50% atrocytes, 40% neurons, and 10% microglia and other cell types, as demonstrated previously (Kim et al, 2000; Liu et al, 2000).”
BackgroundWang, A., Shulman, M., Choo, T.-H. J., Pavlicová, M., Langleben, D. D., Nunes, E. V., & Rotrosen, J. (2021) · Addiction Biology · doi:10.1111/adb.13112 · Cited by 5
“Another explanation could be that XR-NTX reduced pain through its anti-inflammatory effects.(37) This is supported by previous studies showing naltrexone's antagonist effect on central nervous system immune cells (e.”
ResultBrewer, K. L., Tran, T. D., & Meggs, W. J. (2015) · Journal of Medical Toxicology · doi:10.1007/s13181-015-0480-1 · Cited by 5
“agent with anti-inflammatory properties [18, 19], was found to prevent deficits in spatial learning in rats given lethal doses of DFP [6].”
BackgroundPolati, E., Nizzero, M., Rama, J., Martini, A., Gottin, L., Donadello, K., Balzo, G. D., Varrassi, G., Marinangeli, F., Vittori, A., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192013354 · Cited by 5
“In animal models, naloxone was reported to inhibit microglia activation and superoxide generation and thus protect neurons from injuries [33].”
BackgroundChen, J.-F., Fan, J., Tian, X.-W., & Tang, T.-S. (2012) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.4314/ajtcam.v9i2.8 · Cited by 5
Gao, H., Tu, D., Gao, Y., Liu, Q., Yang, R., Liu, Y., Guan, T., & Hong, J. (2017) · Advances in neurotoxicology · doi:10.1016/bs.ant.2017.07.005 · Cited by 6
Self-citationBendiks, S., Cheng, D. M., Blokhina, E. A., Vetrova, M., Verbitskaya, E. V., Gnatienko, N., BRYANT, K. J., Krupitsky, E. M., Samet, J. H., & Tsui, J. I. (2021) · AIDS Care · doi:10.1080/09540121.2021.1896663 · Cited by 4
“…including increased production of endogenous opioids or upregulation of opioid receptors (Brown & Panksepp, 2009), as well as research suggesting inhibition of microglia (Chang et al., 2000; Hutchinson et al., 2008; Liu et al., 2000) and suppression of inflammatory cytokines (Liu et al., 2006).”
Background
Metadata
- Authors
- Liu, B., Du, L., & Hong, J.-S.
- Affiliations
- National Institutes of Health (US)
- National Institute of Environmental Health Sciences (US)
- Corresponding author
- Liu, Bin
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2000-04
- Volume
- 293
- Issue
- 2
- Pages
- 607-617
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W1891696008
- Cited by
- 347
- References
- 43
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 11 · 2022: 11 · 2021: 10 · 2020: 5 · 2019: 2 · 2018: 7 · 2017: 12 · 2016: 10 · 2015: 16 · 2014: 11 · 2013: 13 · 2012: 26
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- naloxone, dopaminergic neurons, Parkinson's disease, microglial activation, lipopolysaccharide, neuroinflammation, oxidative stress, superoxide, neuroprotection, substantia nigra, opioid antagonists, peroxynitrite, nitric oxide, inflammatory cytokines
- MeSH terms
- Animals, Cells, Cultured, Dopamine, Immunohistochemistry, Inflammation, Interleukin-1, Lipopolysaccharides, Mesencephalon, Naloxone, Narcotic Antagonists, Neurons, Nitrates, Nitrites, Rats, Inbred F344, Stereoisomerism, Substantia Nigra, Superoxides, Tumor Necrosis Factor-alpha, Tyrosine 3-Monooxygenase, Oxidants, Microglia, Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 3, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review